Browse articles from EyeWorld.org related to glaucoma. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Positive topline Phase 3 confirmatory trial results for transepithelial crosslinking ➤ 18-month data from first-in-human drug-eluting IOL ➤ New Phase 2 findings for investigational geographic atrophy treatment ➤ Study: long-term, low-dose antiviral treatment reduces risk for HZO patients ➤ Acquisition news ➤ ASCRS news and events
“In this issue, we delve into some of the challenges of common glaucoma surgeries, as well as discuss exciting new technology that may provide us an opportunity to overcome barriers and provide high-quality care in a safer and more predictable fashion,” said Manjool Shah, MD, Glaucoma Editor, in his introduction.
Various patient scenarios, combined with surgeon preferences and comfort with the procedures, dictate tube shunt placement for glaucoma patients. The different placement options allow the surgeons to knock down obstacles in order to set the patient up for the greatest likelihood of tube shunt success.
Two surgeons shared their insights on the pearls they have gained using the XEN Gel Stent (AbbVie), which originally received FDA approval in 2016.
➤ Research: quest for cataract reversal continues ➤ First allogenic cell therapy for treating corneal endothelial disease ➤ Enrollment complete in Phase 2b geographic atrophy treatment study ➤ European agency maintains negative opinion for intravitreal pegcetacoplan for geographic atrophy ➤ Companies partner to further development of new glaucoma drug ➤ ASCRS news and events
SLT has gained popularity in the treatment of glaucoma, and there are several new laser technologies and procedures in various stages of development. Glaucoma specialists spoke with EyeWorld about a few of the newer options and what they’re excited about.
➤ Whole-eye transplant 1 year later ➤ Phase 3 trial investigating new presbyopia drop therapy begins ➤ Study reports on multi-interventional glaucoma technique ➤ Topline results from Phase 3 trial for drug for active thyroid eye disease ➤ Pilot study complete for AMD treatment ➤ ASCRS news and events
➤ ASCRS mourns death of I. Howard Fine, MD ➤ New non-diffractive monofocal and toric IOLs ➤ 36-month results from clinical trials for new glaucoma device ➤ FDA grants IND to stem cell therapy intended to treat photoreceptor diseases ➤ Company launches ophthalmology-specific contract research organization ➤ ASCRS news and events
➤ Study: ocular manifestations of Mpox ➤ ‘World’s first’ spiral IOL designed with artificial intelligence ➤ First-in-human implantation of wireless IOP sensor ➤ Final patient visit for Phase 2 wet AMD treatment trial ➤ Enrollment, dosing complete for Phase 1 AMD, DME therapy ➤ ASCRS news and events
➤ NDA submitted for presbyopia treatment ➤ FDA approves AMD treatment ➤ Primary endpoint achieved in Phase 3 trial of reproxalap for dry eye ➤ Clinical trial results that supported new excimer laser approval published ➤ Company updates on several clinical trials ➤ First patient dosed in Phase 2 trial for intravitreal steroid implant for DME treatment ➤ ASCRS news and events